Ixchiq Vaccine
Who should get vaccinated?
Ixchiq is approved for:
- Adults aged 18 years and older
- Travellers to areas where chikungunya is common or experiencing outbreaks
- Individuals at increased risk of severe disease
Dosage schedule
- Single-dose vaccine
- Provides protection after one injection
Booster requirement
- Booster doses are not currently recommended
Administration method
- Given as an injection in the upper arm
Possible side effects
- Common side effects include:
- Pain or tenderness at the injection site
- Headache
- Fatigue
- Muscle pain
- Fever
- Joint pain
These side effects are usually mild to moderate and resolve within a few days.